Pharmacogenomics and Cancer

• Pharmacogenomics in Cancer—National Cancer Institute
• The Pharmacogenetics of Anti-Cancer Agents Research Group
• Pharmacogenetics in Cancer Treatment—NIH, NCBI
• Pharmacogenomics and Cancer Chemotherapeutics 

Pharmacogenetics and Cardiovascular Disease

• Article: Pharmacogenetics and cardiovascular disease: impact on drug response and applications to disease management

Pharmacogenomics and Neurological Disease & Pain Management
Presentations from a conference September, 2005

• Presentation: Case Studies -- Bipolar and Other Psychiatric Disorders Neil B. Sandson, MD
• Presentation: Individualized Medicine in Neurological Disease: Purpose, Potential and Promise Gregory L. Kearns, Pharm.D., Ph.D.
• Presentation: Neurological and Psychiatric Drug Interactions: The Cytochrome P450 System and Beyond Neil B. Sandson, MD
• Presentation: Pharmacogenetics and its potential contribution to personalized management of neurological disease, Gwen McMillin, PhD
• Presentation: Case Studies: Pain, Migraine, Neuropathy, Gwen McMillin, PhD
• Pharmacogenetics of antidepressants and antipsychotics
  Note:  This is a commercial site with recommendations for antidepressant and antipsychotic dosing based on PGx data